GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Liabilities-to-Assets

CAMRF (Camurus AB) Liabilities-to-Assets : 0.12 (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Camurus AB's Total Liabilities for the quarter that ended in Dec. 2024 was $42.5 Mil. Camurus AB's Total Assets for the quarter that ended in Dec. 2024 was $342.0 Mil. Therefore, Camurus AB's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 was 0.12.


Camurus AB Liabilities-to-Assets Historical Data

The historical data trend for Camurus AB's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Liabilities-to-Assets Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.22 0.24 0.22 0.12

Camurus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.14 0.15 0.13 0.12

Competitive Comparison of Camurus AB's Liabilities-to-Assets

For the Biotechnology subindustry, Camurus AB's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camurus AB's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camurus AB's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Camurus AB's Liabilities-to-Assets falls into.


;
;

Camurus AB Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Camurus AB's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Liabilities-to-Assets (A: Dec. 2024 )=Total Liabilities/Total Assets
=42.543/342.013
=0.12

Camurus AB's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2024 is calculated as

Liabilities-to-Assets (Q: Dec. 2024 )=Total Liabilities/Total Assets
=42.543/342.013
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB  (OTCPK:CAMRF) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Camurus AB Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Camurus AB's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Q3 2022 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2024 Camurus AB Earnings Call Transcript

By GuruFocus News 02-14-2025

Half Year 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q2 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q4 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 02-28-2024

Nine Months 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2019 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024